February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Enes Erul: Trastuzumab deruxtecan shows promise in HER2-mutant solid tumors
May 9, 2024, 00:21

Enes Erul: Trastuzumab deruxtecan shows promise in HER2-mutant solid tumors

Enes Erul, Oncology Fellow at Ankara Üniversitesi, shared on X:

“Trastuzumab deruxtecan shows promise in HER2-mutant solid tumors, with a 29.4% objective response rate in heavily treated patients. Safety profile manageable, supporting further investigation across tumor types.

Enes Erul Enes Erul

Source: Enes Erul/X